comparemela.com
Home
Live Updates
Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma : comparemela.com
Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma
Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the significance of the FDA approval of cilta-cel in relapsed/refractory multiple myeloma.
Related Keywords
New York ,
United States ,
Saadz Usmani ,
,
Johnson ,
Oncologic Drugs Advisory Committee ,
Janssen Biotech Inc ,
Meeting Of The Oncologic Drugs Advisory Committee ,
Drugs Advisory Committee ,
Myeloma Service ,
Memorial Sloan Kettering Cancer Center ,
comparemela.com © 2020. All Rights Reserved.